Specifically, the risk score was significantly correlated with the expression levels of PD−L1, PD−1, CTLA4, IDO1, LAG3, and TIM3 in the biopsies of GBM patients (Figure 3B). The gene discussed is HAVCR2; the disease is glioblastoma.